Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study

The inclusion of RMM information in relevant CPGs is remarkably limited. It may be explained by characteristics of CPGs and of RMMs as well as lack of connection between national regulators and organisations and authors developing CPGs. More collaboration between stakeholders, national regulators and the EMA may advance implementation.

Authors

Institutions

Publication Details

Journal
Drug Safety
Published
2024-11-21
DOI
https://doi.org/10.1007/s40264-024-01487-5
Citations
4
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
4.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study

Ana Marta Silva, Elita Poplavska, Mathias Møllebæk, Inês Ribeiro‐Vaz et al.
4 citations
Drug Safety
Health Systems, Economic Evaluations, Quality of Life
4.52
article

Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study

Ana Marta Silva, Elita Poplavska, Mathias Møllebæk, Inês Ribeiro‐Vaz, Teresa Leonardo Alves, Fariba Ahmadizar, Ieva Rutkovska, Alexia Bikou, Christos Kontogiorgis, Ana Kodrič, Mitja Kos, Renske J. Grupstra, Helga Gardarsdóttir, Anna Birna Almarsdóttir, Foteini Dermiki‐Gkana, Armin Andersen, Paula Barão
article en
4 citations

Abstract

The inclusion of RMM information in relevant CPGs is remarkably limited. It may be explained by characteristics of CPGs and of RMMs as well as lack of connection between national regulators and organisations and authors developing CPGs. More collaboration between stakeholders, national regulators and the EMA may advance implementation.

Drug SafetyVol. 48(2)
University of Copenhagen (DK), University of Lisbon (PT), Democritus University of Thrace (GR), University of Ljubljana (SI), University of Iceland (IS), Universidade do Porto (PT), Utrecht University (NL), University Medical Center Utrecht (NL), National Institute for Public Health and the Environment (NL), Riga Stradiņš University (LV)
Københavns Universitet, European Medicines Agency
Openalex Percentile: Top 5%
Health Systems, Economic Evaluations, Quality of Life
4.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.